Release Date: 26/04/17 09:16 Summary: Daily share buy-back notice - Appendix 3E Price Sensitive: No Download Document 81.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%